1994
DOI: 10.1007/bf00182360
|View full text |Cite
|
Sign up to set email alerts
|

Radiopharmaceuticals and the gastrointestinal tract

Abstract: A review is presented of the design of radiolabelled test meals for the evaluation of gastrointestinal function, including oesophageal transit, gastro-oesophageal reflux, gastric emptying, enterogastric reflux and transit through the whole bowel. Descriptions of different systems are presented, together with validations of the procedures used. Published methods for assessment of oesophageal transit show a marked degree of consistency, whereas gastric emptying studies employ a wide range of both liquid and soli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

1995
1995
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 50 publications
0
6
0
Order By: Relevance
“…The main disadvantage of the use of 99m Tc is that 99m Tc pertechnetate is selectively concentrated in the stomach after oral or intravenous administration [15]. Therefore, it is important that there is high stability binding of the 99m Tc pertechnetate to the paediatric test meal [16]. The stability of binding is poor if the 99m Tc pertechnetate is simply mixed into the test meal [6].…”
Section: Technetium 99m-labelled Crispy Cakementioning
confidence: 99%
“…The main disadvantage of the use of 99m Tc is that 99m Tc pertechnetate is selectively concentrated in the stomach after oral or intravenous administration [15]. Therefore, it is important that there is high stability binding of the 99m Tc pertechnetate to the paediatric test meal [16]. The stability of binding is poor if the 99m Tc pertechnetate is simply mixed into the test meal [6].…”
Section: Technetium 99m-labelled Crispy Cakementioning
confidence: 99%
“…At 08.30 hours the subject injected his usual morning dose of insulin subcutaneously (24 ± 17.6 IU, mean ± SD) and, at 09.00 hours, within 10 min, ate a test meal consisting of turkey, potatoes, vegetables (including mushrooms) and low-fat milkshake which provided 50 % carbohydrate (of which 70 % was starch), 35 % fat, 15 % protein with a total of 600 kcal. The mushrooms were labelled with 3 MBq non-absorbable 99m Tc tin colloid, and the milkshake with 0.5 MBq non-absorbable 111 In-DTPA-diethylenetriaminepentaacetic acid (DTPA) [6]. The milkshake also contained 3-OMG so that its appearance in the peripheral circulation could be used as an index of glucose absorption.…”
mentioning
confidence: 99%
“…In 1989, Camilleri et al [3] from Mayo Clinic, USA, successfully developed a method of indium-111 (III) chloride ( 111 InCl 3 )-radiolabelled resin pellets for the assessment of gastric emptying and colonic transit. Amberlite IR-120 (H + ) cation resin pellets were successfully labelled with 111 InCl 3 , and this method has been widely practised in many centres, particularly for whole-gut transit studies [4][5][6][7]. This method, however, has certain limitations restricting its application to a broader population, mainly because of the requirement of an industrial cyclotron facility for the production of 111 In, which is not commonly available worldwide.…”
Section: Introductionmentioning
confidence: 98%